Anew Medical (WENA) Financials

Balance sheets

30 June 202401 Mar 202401 June 202301 June 2022

Total Assets

$3.3 M(+41.3%)$2.3 M(+3.1%)$2.3 M-

Current Assets

$999.8 K(+2995.5%)$32.3 K(-22.0%)$41.4 K-

Non Current Assets

$2.3 M(0%)$2.3 M(+3.6%)$2.2 M-

Total Liabilities

$4.9 M(+145.3%)$2.0 M(+29.6%)$1.5 M-

Current Liabilities

$898.6 K(-54.7%)$2.0 M(+29.6%)$1.5 M-

Long Term Liabilities

$4.0 M(+100.0%)$0.0(0%)$0.0-

Shareholders Equity

-$1.6 M(-530.9%)$360.0 K(-51.5%)$742.3 K-

Book Value

-$3.9 M(-1174.3%)$359.4 K(-51.5%)$741.8 K-

Working Capital

$101.3 K(+105.2%)-$1.9 M(-31.1%)-$1.5 M-

Cash And Cash Equivalents

$845.3 K(+2517.1%)$32.3 K(-20.1%)$40.4 K-

Accounts Payable

$34.0 K(-92.6%)$460.2 K(+164.0%)$174.3 K-

Accounts Receivable

----

Short Term Debt

-$1.3 M(-1.1%)$1.3 M-

Long Term Debt

$3.9 M---

Total Debt

$3.9 M(+192.7%)$1.3 M(-1.1%)$1.3 M(+100.0%)$0.0

Debt To Equity

-2.5(-167.8%)3.7(+103.3%)1.8-

Current Ratio

1.1(+5450.0%)0.0(-33.3%)0.0-

Quick Ratio

----

Inventory

----

Retained Earnings

-$5.5 M(-20.4%)-$4.6 M(-25.9%)-$3.7 M-

PB Ratio

-7.0(-102.2%)325.5--

Income statements

30 June 202401 Mar 202401 June 202301 June 2022

EPS

-$0.0(-4900.0%)-$0.0(+97.6%)-$0.0(-12250.0%)-$0.0

TTM EPS

-$0.0(-20.9%)-$0.0(-2.4%)-$0.0(-12250.0%)-$0.0

Revenue

$0.0---

TTM Revenue

$0.0---

Total Expenses

$395.6 K(-41.1%)$672.0 K(+175.1%)$244.3 K(+6.4%)$229.6 K

Operating Expenses

$395.6 K(-41.1%)$672.0 K(+175.1%)$244.3 K(+6.4%)$229.6 K

Cost Of Goods Sold

----

TTM Cost Of Goods Sold

----

Gross Profit

----

TTM Gross Profit

----

Gross Margin

----

Operating Profit

-$395.6 K(+41.1%)-$672.0 K(-175.1%)-$244.3 K(-6.4%)-$229.6 K

TTM Operating Profit

-$1.1 M(-16.5%)-$916.3 K(-275.1%)-$244.3 K(-6.4%)-$229.6 K

Operating Margin

----

Net Income

-$451.6 K(+32.8%)-$672.0 K(-154.2%)-$264.4 K(-15.3%)-$229.4 K

TTM Net Income

-$1.1 M(-20.0%)-$936.4 K(-254.2%)-$264.4 K(-15.3%)-$229.4 K

Net Margin

----

EBIT

-$436.6 K(+35.0%)-$672.0 K(-175.2%)-$244.2 K(-6.5%)-$229.4 K

TTM EBIT

-$1.1 M(-21.0%)-$916.2 K(-275.2%)-$244.2 K(-6.5%)-$229.4 K

EBITDA

-$396.9 K(+40.9%)-$672.0 K(-175.2%)-$244.2 K(-6.5%)-$229.4 K

TTM EBITDA

-$1.1 M(-16.7%)-$916.2 K(-275.2%)-$244.2 K(-6.5%)-$229.4 K

Selling, General & Administrative Expenses

$395.6 K(-41.1%)$672.0 K(+175.1%)$244.3 K(+6.4%)$229.6 K

TTM SG&A

$1.1 M(+16.5%)$916.3 K(+275.1%)$244.3 K(+6.4%)$229.6 K

Depreciation And Amortization

----

TTM D&A

----

Interest Expense

$15.1 K(+100.0%)$0.0(-100.0%)$20.2 K(+100.0%)$0.0

TTM Interest Expense

$15.1 K(-25.4%)$20.2 K(0%)$20.2 K(+100.0%)$0.0

Income Tax

$0.0---

TTM Income Tax

$0.0---

PE Ratio

----

PS Ratio

----

Cashflow statements

30 June 202401 Mar 202401 June 202301 June 2022

Cash From Operations

--$22.0 K(+91.7%)-$265.4 K(+22.3%)-$341.6 K

TTM CFO

--$287.4 K(-8.3%)-$265.4 K(+22.3%)-$341.6 K

Cash From Investing

--$123.5 K(-517.5%)-$20.0 K(-100.0%)$0.0

TTM CFI

--$143.5 K(-617.5%)-$20.0 K(-100.0%)$0.0

Cash From Financing

-$175.0 K(-30.0%)$250.0 K(0%)$250.0 K

TTM CFF

-$425.0 K(+70.0%)$250.0 K(0%)$250.0 K

Free Cash Flow

--$145.5 K(+49.0%)-$285.4 K(+16.4%)-$341.6 K

TTM FCF

--$430.9 K(-51.0%)-$285.4 K(+16.4%)-$341.6 K

CAPEX

----

TTM CAPEX

----

Dividends Paid

----

TTM Dividends Paid

----

TTM Dividend Per Share

----

TTM Dividend Yield

----

Payout Ratio

----